AZN Research and Charts

AZN - AstraZeneca PLC ADR (Healthcare: Drug Manufacturers - General)

Projected Earnings Date: 2025-02-11 (Delayed quote data 2025-01-03)

Last 66.25	Change ⇑ +0.37 (+0.56%)	Volume 3,863,732
	Open 66.45	High 66.47	Low 66.12

8EMA (Daily) 66.00	40EMA (Daily) 67.52	50EMA (Daily) 68.31	STO (Daily) 50.710	MACD Hist (Daily) 0.270
8EMA (Weekly) 67.295	40EMA (Weekly) 72.31	50EMA (Weekly) 72.24	STO (Weekly) 19.366	MACD Hist (Weekly) -1.535


Company Profile
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.